SFCM
CRBP icon

Seven Fleet Capital Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Seven Fleet Capital Management’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Sell
21,432
-64,255
-75% -$608K 0.03% 91
2026
Q1 		$805K Buy
85,687
+28,937
+51% +$244K 0.25% 69
2025
Q4 		$462K Buy
+56,750
New +$700K 0.31% 49

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Seven Fleet Capital Management's CRBP Position: Q2 2026 in Review

Seven Fleet Capital Management reduced its Corbus Pharmaceuticals (CRBP) stake by 75% in Q2 2026, selling an estimated $608K and leaving 21,432 shares worth $201K. The position accounts for 0.03% of the portfolio, ranked #91.

Seven Fleet Capital Management first reported a position in CRBP in Q4 2025 and has held it in 3 quarters since. The position peaked at $805K in Q1 2026. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Seven Fleet Capital Management held 21,432 shares of Corbus Pharmaceuticals worth $201K as of Q2 2026.
  • Seven Fleet Capital Management sold 64,255 Corbus Pharmaceuticals shares in Q2 2026, an estimated $608K.
  • Corbus Pharmaceuticals made up 0.03% of Seven Fleet Capital Management's portfolio in Q2 2026, its #91 holding.
  • Seven Fleet Capital Management first reported a position in Corbus Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Seven Fleet Capital Management's Corbus Pharmaceuticals position peaked at $805K in Q1 2026.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Seven Fleet Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.